DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) CEO Allan C. Thygesen sold 7,911 shares of the company’s stock in a transaction dated Monday, July 1st. The shares were sold at an average price of $53.77, for a total transaction of $425,374.47. Following the completion of the sale, the chief executive officer now directly owns 117,643 shares of the company’s stock, valued at approximately $6,325,664.11. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
DocuSign Stock Performance
NASDAQ DOCU opened at $54.13 on Friday. The firm has a market cap of $11.08 billion, a price-to-earnings ratio of 104.10, a PEG ratio of 4.52 and a beta of 0.94. The firm has a 50 day simple moving average of $55.53 and a 200-day simple moving average of $56.69. DocuSign, Inc. has a one year low of $38.11 and a one year high of $64.76.
DocuSign (NASDAQ:DOCU – Get Free Report) last issued its quarterly earnings results on Thursday, June 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.20 by $0.09. DocuSign had a net margin of 3.81% and a return on equity of 15.44%. The company had revenue of $709.64 million during the quarter, compared to analysts’ expectations of $706.07 million. Equities analysts predict that DocuSign, Inc. will post 0.88 EPS for the current fiscal year.
Institutional Investors Weigh In On DocuSign
Wall Street Analyst Weigh In
Several equities analysts have weighed in on DOCU shares. Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a report on Friday, June 7th. JMP Securities reiterated a “market outperform” rating and issued a $84.00 price objective on shares of DocuSign in a research report on Friday, June 7th. UBS Group upgraded DocuSign from a “sell” rating to a “neutral” rating and lifted their target price for the company from $48.00 to $62.00 in a research report on Friday, April 12th. Robert W. Baird lowered their price target on DocuSign from $65.00 to $55.00 and set a “neutral” rating for the company in a report on Friday, June 7th. Finally, Morgan Stanley reduced their price objective on shares of DocuSign from $65.00 to $62.00 and set an “equal weight” rating on the stock in a report on Friday, June 7th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $59.36.
Read Our Latest Stock Analysis on DOCU
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
- Five stocks we like better than DocuSign
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Consumer Discretionary Stocks Explained
- AbbVie Stock: A Perfect Dip for Investors to Buy
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.